Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign. Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy. Thus, this study aims to compare the SpO2 values of different oximeters (General Electric-GE, Medtronic, Masimo and Nonin) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation

Eligibility
Participation Requirements
Sex: All
Maximum Age: 100
Healthy Volunteers: f
View:

• ≥ 18 years old (adult population) -

• Patients admitted to the Intensive Care Unit

• Artery catheter already installed

⁃ Pediatric population

• Below 18 years old

• Patients admitted to the Intensive Care Unit

• Artery catheter already installed

Locations
Other Locations
Canada
CHU Ste-Justine
NOT_YET_RECRUITING
Montreal
CHUM
RECRUITING
Montreal
Institut Universitaire de Cardiologie et de Pneumologie de Québec
NOT_YET_RECRUITING
Québec
Time Frame
Start Date: 2024-06-20
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 200
Treatments
Pediatric population
Pediatric population \< 18 years old (estimated 100 patients)
Adult population
Adult population \>or= 18 years old (estimated 100 patients)
Related Therapeutic Areas
Sponsors
Leads: Laval University

This content was sourced from clinicaltrials.gov